Electromed IncELMD
Price$28.50Intrinsic value$41.1744% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $41.17median of 6 methods · middle span $24-$91based on filings through 31 Mar 2026
Market Price $28.50Price as of 1 Oct 2026
Margin of Safety +44.5%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 21.7% (near-term consensus, capped) · years 2–5: 16.1%/yr (balance of the path).17.2% per year
Years 6–10: glide to demonstrated growth own history 28.1%, capped at 20%
Per-year rates
Yr 616.3%Yr 716.5%Yr 816.7%Yr 916.9%Yr 1017.2%
16.1% → 17.2%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1115.7%Yr 1214.3%Yr 1312.9%Yr 1411.5%Yr 1510.1%Yr 168.7%Yr 177.2%Yr 185.8%Yr 194.4%Yr 203.0%
17.2% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)28.1%
Discount rate (cost of equity) 8.0%
Volatility vs market (adjusted beta)0.68

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetElectromed IncELMDHealth Care
Valuation
P/E21.9×
P/S3.0×
P/B4.3×
EV / Revenue2.7×
EV / EBITDA20.1×
Profitability
Gross margin78.4%
Operating margin18.3%
Net margin15.3%
FCF margin11.4%
Returns
ROE20.9%
ROA17.1%
ROIC33.7%
Growth
Revenue growth (YoY)15.3%
5-yr fwd EPS growth17.2%
Financial strength
Debt / Equity0.00×
Current ratio4.69×
Altman Z-Score14.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.